About Neurolytixs
Neurolytixs is a Healthcare company based in Toronto (Canada) founded in 2020 by Douglas Fraser and Adrian Uthay. It offers artificial intelligence services to diagnose concussions with blood biomarkers test. Its focus areas include Services for Healthcare Providers, BPO, Outsourced Clinical Services and Medical Consultation.
Company details
Neurolytixs was founded in 2020 and is based in Toronto, Canada. Operations focus on the health technology sector, where artificial intelligence is applied to analyze blood biomarkers for concussion detection. Services include diagnostic testing and AI-driven assessments to support medical evaluations. The company is led by founder Douglas Fraser and co-founder Adrian Uthay, with activities centered on advancing neurological diagnostics through biomarker innovation.
- Headquarters Toronto, Canada
- Founders Douglas Fraser, Adrian Uthay
- SectorsHealthcare
- Website neurolytixs.com
- Social LinkedIn
People of Neurolytixs
2 people are tracked at Neurolytixs (2 in leadership).
| Name | Role | Group |
|---|---|---|
Douglas Fraser | Founder | Leadership |
Adrian Uthay | Co-Founder | Leadership |
Complete people profiles for Neurolytixs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Neurolytixs
Complete news archive for Neurolytixs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neurolytixs
Neurolytixs was founded in 2020.
Neurolytixs is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Neurolytixs was founded in 2020 and is based in Toronto, Canada. Operations focus on the health technology sector, where artificial intelligence is applied to analyze blood biomarkers for concussion detection. Services include diagnostic testing and AI-driven assessments to support medical evaluations. The company is led by founder Douglas Fraser and co-founder Adrian Uthay, with activities centered on advancing neurological diagnostics through biomarker innovation.